These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2564657

  • 1. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
    Lacroix H, Iglehart JD, Skinner MA, Kraus MH.
    Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
    [Abstract] [Full Text] [Related]

  • 2. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.
    Cancer Res; 1990 Oct 15; 50(20):6701-7. PubMed ID: 2208136
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 15; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 4. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 5. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ, Jordan PA, Huper G, Marks JR, Iglehart JD, Layfied LJ.
    Mod Pathol; 1993 Nov 15; 6(6):673-8. PubMed ID: 7905629
    [Abstract] [Full Text] [Related]

  • 6. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 7. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M.
    Cancer Res; 1994 Apr 01; 54(7):1825-30. PubMed ID: 7907945
    [Abstract] [Full Text] [Related]

  • 8. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S.
    Anticancer Res; 1993 Apr 01; 13(5A):1293-301. PubMed ID: 7902061
    [Abstract] [Full Text] [Related]

  • 9. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M.
    Mod Pathol; 1992 Jul 01; 5(4):384-90. PubMed ID: 1353880
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.
    King CR, Swain SM, Porter L, Steinberg SM, Lippman ME, Gelmann EP.
    Cancer Res; 1989 Aug 01; 49(15):4185-91. PubMed ID: 2568168
    [Abstract] [Full Text] [Related]

  • 11. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 12. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ, Robbins PD, Smith KL, Sarna M, Harvey JM, Sterrett GF, Papadimitriou JM.
    Pathol Res Pract; 1993 Dec 01; 189(10):1233-52. PubMed ID: 7910395
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.
    Oncogene Res; 1988 Dec 01; 3(1):21-31. PubMed ID: 2905033
    [Abstract] [Full Text] [Related]

  • 14. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
    Fernandez-Pol JA.
    Crit Rev Oncog; 1991 Dec 01; 2(2):173-85. PubMed ID: 1677274
    [Abstract] [Full Text] [Related]

  • 15. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E.
    Cancer Res; 1989 Dec 01; 49(23):6675-9. PubMed ID: 2573420
    [Abstract] [Full Text] [Related]

  • 16. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH.
    Cancer Res; 1989 Dec 01; 49(23):6605-9. PubMed ID: 2573419
    [Abstract] [Full Text] [Related]

  • 17. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.
    Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, Hynes NE.
    Cancer Res; 1988 Mar 01; 48(5):1238-43. PubMed ID: 2893663
    [Abstract] [Full Text] [Related]

  • 18. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
    Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R.
    Cancer Res; 1993 Nov 01; 53(21):5251-61. PubMed ID: 8106145
    [Abstract] [Full Text] [Related]

  • 19. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
    Ethier SP, Kokeny KE, Ridings JW, Dilts CA.
    Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.
    Cancer Res; 2000 Jun 01; 60(11):3081-7. PubMed ID: 10850460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.